ClinicalTrials.Veeva

Menu

European Pathology Laboratories and COVID-19

C

Centre Hospitalier Universitaire de Nice

Status

Completed

Conditions

Clinical Practice During the COVID-19 Crisis

Treatments

Other: Activity

Study type

Observational

Funder types

Other

Identifiers

NCT04476823
20labocovid01

Details and patient eligibility

About

The infectivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), notably when handling human samples, remains poorly understood, as well as the impact of the COVID-19 pandemic in routine clinical and molecular pathology practice, and for personal working in pathology laboratories. This study evaluates the consequences of the COVID-19 crisis in clinical and molecular pathology laboratories in Europe mostly those orientated for diagnosis of thoracic diseases.

Enrollment

71 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • laboratories following the COVID-19 crisis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems